News and Announcements
Kinesis Monetary System signs agreement with leading North American security token exchange company
- Published October 02, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Kinesis Monetary System signs MOU with Hyperion Exchange.
- Hyperion Exchange is a leading exchange company for security tokens in Northern America.
- Kinesis Monetary System are delighted to have new participants and allow more accessibility to the Kinesis Monetary System platform.
Kinesis Monetary System has signed an MOU with Hyperion Exchange.
Hyperion Exchange allows investors to efficiently trade digital tokens using blockchain technology.
The MOU will allow investors regulator confidence and complete trades at a more efficient, lower cost method than traditional stock markets.
The MOU will allow Kinesis Velocity Tokens will be listed on the Hyperion Exchange platform and Kinesis gold and silver currencies available as stable coins.
Hyperion has said that Kinesis is the ‘perfect stablecoin fit’ for their platform.
The MOU allows investors to trade from volatile cryptocurrency positions.
Kinesis Monetary Systems have sold in excess of US$50 million worth of Kinesis Velocity Tokens and are hoping this number will increase with the new agreement.
About Kinesis Monetary Systems
The vision for Kinesis is to deliver an evolutionary step beyond any monetary system available today. This is achieved by basing the Kinesis currencies 1:1 on allocated physical gold and silver. Use is incentivised by attaching a unique yield system to the Kinesis currencies and distributing back the wealth generated according to proportionate currency holdings and velocity.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
